Uli Hacksell

Uli Hacksell is a declared insider at 2 companies; the most frequent names are Medivir Aktiebolag and SynAct Pharma AB. Between 3 May 2022 and 16 February 2024, the trades on record add up to 4 filings.

No open-market sale appears; the market trades are 3 purchases worth €66k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2024 to date brings 1 purchase and no sales.

In size, the median ticket on the buying side is €28k. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 16 February 2024, reports an open-market purchase of €28k in Medivir Aktiebolag. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.